RxDoctor Payments Data

Thomas Pfiffner, MD

Neurology · Buffalo, NYNPI 1477780054

Payments from drug & device makers

$208,666in general payments, 2019–2025

Across 567 payments — averaging $368.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurology Practice Consortium GPO, LLC$198K
  • MDD US Operations, LLC$1K
  • Teva Pharmaceuticals USA, Inc.$817
  • AbbVie$569
  • SK Life Science, Inc.$565
  • Lundbeck LLC$525
  • plus $7K from 54 others

What the payments were for

  • Speaking & faculty fees$430%
  • Food & beverage$10,605100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Neurology Practice Consortium GPO, LLC6$198,018
MDD US Operations, LLC45$1,374
Teva Pharmaceuticals USA, Inc.39$817
AbbVie(2 entities)15$569
SK Life Science, Inc.23$565
Lundbeck LLC24$525
Jazz Pharmaceuticals Inc.26$504
Amgen17$433
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC33$404
UCB, Inc.18$390
Novartis13$267
Amneal Pharmaceuticals LLC22$233
AstraZeneca(2 entities)10$225
Livanova USA, Inc.11$219
Abbott10$209
Arbor Pharmaceuticals, Inc.11$208
Neurocrine Biosciences, Inc.12$204
Johnson & Johnson11$201
Promius Pharma LLC5$177
Supernus Pharmaceuticals, Inc.11$171
Biohaven Pharmaceuticals, Inc.48$168
Avanir Pharmaceuticals, Inc.6$148
Pfizer9$144
Axsome Therapeutics, Inc.7$141
Collegium Pharmaceutical, Inc.9$139
Eisai Inc.7$138
Harmony Biosciences LLC6$136
Lilly USA, LLC6$121
Tanabe Pharma America, Inc.7$104
CSL Behring4$104
Acadia Pharmaceuticals Inc6$95
E.r. Squibb & Sons, L.L.C.5$88
Scilex Pharmaceuticals Inc.6$86
Azurity Pharmaceuticals, Inc.4$84
Ipsen Biopharmaceuticals, Inc4$80
Otsuka America Pharmaceutical, Inc.4$79
Sanofi5$71
Nevro Corp.3$70
GE HealthCare9$67
Acorda Therapeutics, Inc3$64
Merz Pharmaceuticals, LLC3$61
Upsher-smith Laboratories LLC3$59
Catalyst Pharmaceuticals, Inc.2$57
Neurelis, Inc.3$52
Biodelivery Sciences International, Inc.4$51
Biogen3$47
GRT US Holding, Inc.3$45
Boston Scientific2$44
Kyowa Kirin, Inc.2$40
Redhill Biopharma Inc.2$40
Almatica Pharma LLC2$39
Zyla Life Sciences, Inc.2$37
Alnylam Pharmaceuticals Inc.2$28
Corium, LLC1$25
Octapharma USA, Inc.1$19
USWM, LLC1$18
Akcea Therapeutics, Inc.1$18
Merck1$17
Greenwich Biosciences, Inc.1$17
Adamas Pharmaceuticals, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$208,666 in reported general payments places this provider in the 90th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York

Medicare billing

Part B allowed, 2024
$507,252
Medicare patients
604
Services billed
11,766

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine13$1,177
Levetiracetam28$926
Divalproex Sodium ErDivalproex Sodium13$507
Donepezil Hcl24$228
Gabapentin12$91

Paid to pharmacies, not to this prescriber.

Other neurology in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →